22265 ⎘
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action Anti-atherosclerotic agents
THERAPEUTIC AGENT FOR USE IN LOCAL TREATMENT OF INFLAMMATION ASSOCIATED WITH ATHEROSCLEROSIS AND/OR A THROMBOTIC STATE
#2Biological Material And Preparation Method Therefor
#3STENT WITH IMMEDIATELY REMOVEABLE COATING
#4METHODS AND COMPOSITIONS FOR TISSUE THERAPY AND ANALYSIS
#5Drug delivery device for peripheral artery disease
#6Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
#7Medical device with coating that promotes endothelial cell adherence
#8Hydrogel coated scaffold
#9Assessment of a drug eluting bioresorbable vascular scaffold
#10Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation
#11Compositions for preventing cardiac arrhythmia
#12Medical device with coating that promotes endothelial cell adherence
#13Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
#14METHODS AND INTRAVASCULAR TREATMENT DEVICES USING PACLITAXEL FOR TREATMENT OF ATHEROSCLEROSIS
#15Compositions for preventing cardiac arrhythmia
#16Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stents
#17Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
#18Drug delivery by carbon nanotube arrays
#19Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease
#20Hygroscopic coating on a balloon device
#21CALMODULIN-BINDING PEPTIDES THAT REDUCE CELL PROLIFERATION IN CANCER AND SMOOTH MUSCLE PROLIFERATION DISEASES
#22Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity
#23Drug-containing nanoparticles
#24Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation
#25Method and Device for Localized Administration of Calcium Chelating Agent
#26Coating construct containing poly(vinyl alcohol)
#27Devices and methods for reverse lipid transport
#28DISSOLUTION OF ARTERIAL PLAQUE
#29Drug-delivery stent formulations for restenosis and vulnerable plaque
#30Coating construct containing poly (vinyl alcohol)
#31Medical Device with Coating that Promotes Endothelial Cell Adherence
#32Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#33Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#34Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#35Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#36Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#37Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#38Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#39Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#40Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#41Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#42Methods and kits-for delivering pharmaceutical agents into the coronary vascular adventitia
#43Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#44Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
#45Drug-delivery stent formulations for restenosis and vulnerable plaque
#46Drug delivery device
#47Medical use of reuterin
#48Method of treating atherosclerosis and hypercholesterolemia
#49Medical device with coating that promotes endothelial cell adherence